ARTV · NASDAQ · Biotechnology

Artiva Biotherapeutics (ARTV)

Develops cryopreserved allogeneic NK-cell candidates for autoimmune diseases and cancer.

$8.09
After hours−0.01 (−0.06%)
At close$8.10(+3.38%)